跳至主要内容
临床试验/NCT00597467
NCT00597467已完成不适用

An Open-Labeled, Multi-Center, Randomized Investigation of the VISA (Comfilcon A) Silicone Hydrogel Soft (Hydrophilic) Contact Lens for Use in a 7 Day Extended Wear Regimen

Coopervision, Inc.23 个研究点 分布在 1 个国家目标入组 460 人开始时间: 2006年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
460
试验地点
23
主要终点
Frequency of serious and significant AEs

研究概览

简要总结

To compare the safety and efficacy of the CVI silicone-hydrogel lens worn on an extended wear basis for a period of up to 7 days and 6 nights with the Acuvue 2 soft contact lenses.

详细描述

To compare the safety and efficacy of the CVI silicone-hydrogel lens worn on an extended wear basis for a period of up to 7 days and 6 nights with the Acuvue 2 soft contact lenses in this open-labeled randomized study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Be at least 18 years of age as of the date of evaluation.
  • •Require lens powers between -0.50 and -6.00 diopters sphere with no more than 1.00 diopter of refractive astigmatism and be willing to wear lenses in both eyes.
  • •Be correctable to visual acuities of at least 20/25 in each eye with spectacles.
  • •Be in good general health, based on his/her knowledge.
  • •Be able and willing to adhere to the instructions set forth in this protocol and able to keep all specified appointments.
  • •Possess wearable and visually functional eyeglasses.

排除标准

  • •Previously unsuccessful with contact lens wear.
  • •Rigid gas permeable contact lens wear within the past 12 months.
  • •Previous refractive surgery; current or previous orthokeratology treatment.
  • •Subject is wearing lenses in a modified monovision modality (multifocal lens in one eye). NOTE: subjects may not wear monovision lenses at any time during the study unless they are wearing spherical monovision lenses prior to enrollment.
  • •Aphakia, keratoconus or an irregular cornea.
  • •A known history of corneal hypoesthesia
  • •Clinically significant (grade 3 or 4) anterior segment abnormalities or any infection of the eye, lids, or associated structures.
  • •Ocular or systemic disease or need for medication which might interfere with contact lens wear. i.e., Sjögren's syndrome, type II diabetes, etc.
  • •Slit lamp findings that would contraindicate contact lens wear, including but not limited to:
  • •History of corneal ulcer, corneal infiltrates or fungal infections.
  • •Pterygium, pinguecula or corneal scars within the visual axis
  • •Pathological dry eye or associated findings (examples: Sjögren's syndrome, lupus erythematosus, sclerodermia)
  • •Neovascularization or ghost vessels > 1mm in from the limbus
  • •Seborrheic eczema, seborrheic conjunctivitis
  • •History of papillary conjunctivitis greater than Grade 2 (Mild)
  • •Anterior uveitis or iritis (past or present)
  • •Known sensitivity to the care systems used in this study.
  • •Poor personal hygiene
  • •Current pregnancy or is lactating (to the best of the subject's knowledge) or subject is planning pregnancy within the next 13 months.
  • •Any active participation in another clinical study within 30 days prior to this study.
  • •Subject is a member, relative or household member of the office staff, including the investigator(s).
  • •Subjects must read, indicate understanding of, and sign the Informed Consent Form.

研究组 & 干预措施

Test Contact Lenses

Experimental

VISA (comfilcon A) Silicone Hydrogel Soft contact lens

干预措施: VISA (comfilcon A) Silicone Hydrogel Soft contact lens (Device)

Control Contact Lenses

Active Comparator

Acuvue 2 Soft Contact Lens

干预措施: Acuvue 2 Soft Contact Lens (Device)

结局指标

主要结局

Frequency of serious and significant AEs

时间窗: 1 Year

Frequency of serious and significant AEs defined as a composite of infiltrates of higher than grade 2 and/or infiltrates with any overlying staining, peripheral ulcer, and loss of two or more lines of visual acuity at any time during the trial

次要结局

  • Contact Lens Visual Acuity(1 Year)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (23)

Loading locations...

相似试验